Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 206619

VIEKIRA PAK (COPACKAGED) (DASABUVIR SODIUM ; OMBITASVIR; PARITAPREVIR; RITONAVIR)
EQ 250MG BASE,N/A,N/A,N/A; N/A,12.5MG,75MG,50MG Marketing Status: Prescription

Active Ingredient: DASABUVIR SODIUM ; OMBITASVIR; PARITAPREVIR; RITONAVIR
Proprietary Name: VIEKIRA PAK (COPACKAGED)
Dosage Form; Route of Administration: TABLET, TABLET; ORAL
Strength: EQ 250MG BASE,N/A,N/A,N/A; N/A,12.5MG,75MG,50MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N206619
Product Number: 001
Approval Date: Dec 19, 2014
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English